Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 101,028Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3MAIA PHARMS INC

02 4SANDOZ

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BIVALIRUDIN

US Patent Number : 11903993

Drug Substance Claim :

Drug Product Claim :

Application Number : 211215

Patent Use Code : U-3817

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-20

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BIVALIRUDIN

US Patent Number : 11918622

Drug Substance Claim :

Drug Product Claim :

Application Number : 211215

Patent Use Code : U-3817

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-20

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BIVALIRUDIN

US Patent Number : 11992514

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211215

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-20

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BIVALIRUDIN

US Patent Number : 7582727

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20873

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-07-27

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BIVALIRUDIN

US Patent Number : 7598343

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20873

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-07-27

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BIVALIRUDIN

US Patent Number : 7582727*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 20873

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-01-27

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BIVALIRUDIN

US Patent Number : 7598343*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 20873

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-01-27

blank